Selexys Pharmaceuticals
A company focused on developing drugs to treat inflammatory and thrombotic diseases.
Launch date
Market cap
-
Enterprise valuation
CAD907m (Public information from Nov 2016)
Oklahoma City Oklahoma (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $3.4m | Debt | |
| N/A | $5.0m | Debt | |
$23.0m | Series A | ||
| N/A | $43.2m | Series B | |
$665m Valuation: $665m | Acquisition | ||
| Total Funding | CAD90.3m | ||